• Return to Headlines

Analyst Downgrades for March 4th

Written on Thu, 03/04/2010 - 9:39am
By Chip Brian

Analyst Downgrades for 3/4/2010... Amylin Pharmaceuticals (NASDAQ:AMLN) downgraded to Underperform, $12 target, at BMO Capital... Avery Dennison (NYSE:AVY) downgraded to Neutral, $35 target, at BofA/Merrill... Cbeyond (NASDAQ:CBEY) downgraded to Equal Weight from Overweight, $15 target, at Stephens... Celera (NYSE:CRA) downgraded to Market Perform from Outperform at JMP Securities... Convergys (NYSE:CVG) downgraded to Sell from Hold, $11 target, at Kaufman Bros... Delphi Financial (NYSE:DFG) initiated as Market Perform at Wells Fargo... Fifth Third Bancorp (NYSE:FITB) downgraded to Market Perform from Outperform at Bernstein... M&T Bank (NYSE:MTB) downgraded to Market Perform from Outperform at Bernstein... Madison Square Garden (NYSE:MSG) initiated as Neutral at UBS... Medivation (NASDAQ:MDVN) downgraded to Neutral from Overweight at JP Morgan... RailAmerica (NYSE:RA) downgraded to Peer Perform from Outperform at Wolfe Research... SeaBright (NYSE:SBX) downgraded to Market Perform from Outperform, $11 target, at Keefe Bruyette...

Keywords: Analyst Upgrades analyst downgrades stock news

Ticker(s): AMLN AVY CBEY CRA CVG DFG FITB MTB MDVN SBX

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.